Clinilabs Revenue and Competitors
Estimated Revenue & Valuation
- Clinilabs's estimated annual revenue is currently $24.7M per year.
- Clinilabs's estimated revenue per employee is $112,200
Employee Data
- Clinilabs has 220 Employees.
- Clinilabs grew their employee count by 6% last year.
Clinilabs's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Clinical Operations | Reveal Email/Phone |
2 | VP, Marketing and Communications | Reveal Email/Phone |
3 | VP Finance | Reveal Email/Phone |
4 | VP Operations | Reveal Email/Phone |
5 | VP Global Clinical Operations | Reveal Email/Phone |
6 | VP Project Solutions | Reveal Email/Phone |
7 | VP, Strategy and Corporate Development | Reveal Email/Phone |
8 | VP, Contracts & Proposals | Reveal Email/Phone |
9 | Director, Clinical Operations | Reveal Email/Phone |
10 | Chief Operating Officer | Reveal Email/Phone |
Clinilabs Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $773.8M | 3120 | 8% | $1.8M | N/A |
What Is Clinilabs?
Clinilabs, Inc. is a privately-held, technology-based clinical trials organization that provides key drug development services to pharmaceutical and biotechnology companies involved in the development of new therapeutic drugs and medical devices. The company offers a wide range of services, including project development, project management, study execution at its dedicated site, electronic data capture and management for multicenter trials, and electronic subject recruitment for multicenter trials.
keywords:N/AN/A
Total Funding
220
Number of Employees
$24.7M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Clinilabs News
Clinilabs has deep expertise in central nervous system drug development. CYB003 will be the first psilocybin analog to be evaluated in Phase 1/...
Clinilabs is to carry out Cybin's Phase 1/2a clinical trial of CYB003 for treating Major Depressive Disorder (MDD). According to the company,...
Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $31.5M | 220 | 26% | N/A |
#2 | $35.1M | 220 | 0% | N/A |
#3 | $35.1M | 220 | 6% | N/A |
#4 | $58.8M | 220 | -5% | N/A |
#5 | $43.6M | 220 | N/A | N/A |